NCT03276195View on ClinicalTrials.gov

Studies in Patients With Tuberous Sclerosis Complex

CompletedOBSERVATIONAL
Enrollment

32

Participants

Timeline

Start Date

May 1, 2016

Primary Completion Date

November 27, 2023

Study Completion Date

November 27, 2023

Conditions
Tuberous Sclerosis Complex
Trial Locations (1)

85004

Translational Genomics Research Institute (TGen), Phoenix

All Listed Sponsors
collaborator

United States Department of Defense

FED

lead

Translational Genomics Research Institute

OTHER

NCT03276195 - Studies in Patients With Tuberous Sclerosis Complex | Biotech Hunter | Biotech Hunter